Subspecialties: Page 1360

CREATE results confirm safety, efficacy of new carotid stenosis system
By Peggy Peck
NEW ORLEANS - A new system for carotid stenting and distal protection has proved itself in a prospective, multicenter trial, according to a presentation Sunday at the Society of Interventional Radiology (SIR) meeting.
April 4, 2005
Focal cryoablation promoted as new paradigm for treating prostate cancer
By Peggy Peck
NEW ORLEANS - Focal cryoablation can target and treat prostate cancer while sparing healthy tissue, according to a presentation Friday at the Society for Interventional Radiology (SIR) meeting. Interventional radiologists in Florida used focal cryoablation to perform a "male lumpectomy" on prostate cancer patients.
April 3, 2005
RFA demonstrates 'surprising' efficacy for treatment of lung malignancies
By Peggy Peck
NEW ORLEANS - What's good for the liver is good for the lung, according to results from a multicenter pilot trial of radiofrequency ablation (RFA). Italian investigators successfully used RFA to treat non-small cell lung cancer (NSCLC) in patients who were not candidates for surgery, external beam radiotherapy, and/or chemotherapy.
April 3, 2005
HeartLab expands archive offerings
By AuntMinnie.com staff writers
Cardiac image management firm Heartlab said it's increasing the capacity of its StoreSafe DVD archive using double-layer DVD technology from PowerFile of Santa Clara, CA.
April 3, 2005
Echo shows more left ventricular hypertrophy, predicts greater risk for Hispanics
By Jerry Ingram
An echocardiogram finding of increased left ventricular mass may portend even greater cardiovascular risk for Hispanics, according to a new study presented at the recent American College of Cardiology (ACC) meeting in Orlando, FL.
April 3, 2005
Oral x-rays indicate likelihood of carotid artery plaque
By Tracie L. Thompson
Panoramic radiography's potential role in assessing atherosclerotic risk is highlighted by a new study that shows an association between findings of periodontal bone loss and carotid plaque thickness.
March 31, 2005
E-Z-EM to move to Nasdaq
By AuntMinnie.com staff writers
Contrast agent and virtual colonoscopy developer E-Z-EM has decided to switch its common stock listing from the American Stock Exchange to the Nasdaq National Market.
March 30, 2005
As cardiac CT interest heats up, so does EBCT, MDCT debate
By Kate Madden Yee
Cardiac imaging with multislice CT scanners is threatening to eclipse electron beam computed tomography, the technology that pioneered CT heart imaging. Although many believe that EBCT retains technical advantages over MDCT, practices are increasingly opting for the cheaper and more clinically versatile MDCT scanners -- raising questions about EBCT's future, according to this Technology Review article.
March 30, 2005
2002 03 13 15 53 59 706
Ultrasound separates fracture from metastasis in the ribs
By Shalmali Pal
Bone scintigraphy of the chest cavity can easily reveal malignant disease to clinicians. However, those clinicians may also have to determine if a site of single rib uptake on bone scintigraphy is a matter of metastasis or simply a fracture. South Korean radiologists have found that ultrasound successfully makes that distinction.
March 30, 2005
2005 03 30 15 45 01 706
Late phase best to differentiate focal liver lesions with CEUS
By N. Shivapriya
Differentiating benign from malignant lesions with contrast-enhanced ultrasound (CEUS) is best done at late phase, and a quantitative analysis of ultrasound video intensity can be used to calculate the conspicuity index for effective and objective differentiation of the liver tumors, according to Italian researchers.
March 28, 2005
2005 03 25 12 26 30 706
Senate hears testimony on virtual colonoscopy
By Eric Barnes
At a recent U.S. Senate Cancer Coalition hearing, a senator and several colon cancer screening experts spoke of the need to increase screening compliance, and about the role of virtual colonoscopy in those efforts.
March 27, 2005
Boston Scientific loses stent verdict
By AuntMinnie.com staff writers
Interventional device manufacturer Boston Scientific of Natick, MA, has lost a jury verdict in a patent infringement case with rival Johnson & Johnson of New Brunswick, NJ, over stent technology.
March 24, 2005
Previous Page
Page 1360 of 1583
Next Page